- Mir-29b in Breast Cancer: A Promising Target for Therapeutic Approaches
Silvia Grassilli et al, 2022, Diagnostics CrossRef - LncRNA PRKCQ‐AS1 regulates paclitaxel resistance in triple‐negative breast cancer cells through miR‐361‐5p/PIK3C3 mediated autophagy
Shurong Zheng et al, 2023, Clinical and Experimental Pharmacology and Physiology CrossRef - Traditional versus progressive robot-assisted gait training in people with multiple sclerosis and severe gait disability: study protocol for the PROGR-EX randomised controlled trial
Andrea Baroni et al, 2024, BMJ Open Sport & Exercise Medicine CrossRef - Vav1 Selectively Down-Regulates Akt2 through miR-29b in Certain Breast Tumors with Triple Negative Phenotype
Silvia Grassilli et al, 2022, Journal of Personalized Medicine CrossRef - Discovering the Biological Significance and Therapeutic Potential of miR-29b-3p in Triple-Negative Breast Cancer
Ancuta Jurj et al, 2023, International Journal of Molecular Sciences CrossRef - Effects of Garlic on Breast Tumor Cells with a Triple Negative Phenotype: Peculiar Subtype-Dependent Down-Modulation of Akt Signaling
Federica Brugnoli et al, 2024, Cells CrossRef